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1The success of emergency coronary reperfusion therapy in ST-segment–elevation myocardial infarction (STEMI) is 
commonly limited by failed tissue perfusion.1 This disconnect 
is mainly because of 2 pathologies: microvascular obstruction2 
and intramyocardial hemorrhage.3 On the basis of morphologi-
cal2 and functional studies,4 microvascular obstruction may 
have structural and functional components,5 reflecting irrevers-
ible (ie, endothelial disruption) and reversible (eg, microvas-
cular spasm and extrinsic edema) components. Myocardial 
Background—The success of coronary reperfusion therapy in ST-segment–elevation myocardial infarction (MI) is 
commonly limited by failure to restore microvascular perfusion.
Methods and Results—We performed a prospective cohort study in patients with reperfused ST-segment–elevation MI who 
underwent cardiac magnetic resonance 2 days (n=286) and 6 months (n=228) post MI. A serial imaging time-course 
study was also performed (n=30 participants; 4 cardiac magnetic resonance scans): 4 to 12 hours, 2 days, 10 days, and 7 
months post reperfusion. Myocardial hemorrhage was taken to represent a hypointense infarct core with a T2* value of 
<20 ms. Microvascular obstruction was assessed with late gadolinium enhancement. Adverse remodeling was defined as 
an increase in left ventricular end-diastolic volume ≥20% at 6 months. Cardiovascular death or heart failure events post 
discharge were assessed during follow-up. Two hundred forty-five patients had evaluable T2* data (mean±age, 58 [11] 
years; 76% men). Myocardial hemorrhage 2 days post MI was associated with clinical characteristics indicative of MI 
severity and inflammation. Myocardial hemorrhage was a multivariable associate of adverse remodeling (odds ratio [95% 
confidence interval]: 2.64 [1.07–6.49]; P=0.035). Ten (4%) patients had a cardiovascular cause of death or experienced 
a heart failure event post discharge, and myocardial hemorrhage, but not microvascular obstruction, was associated 
with this composite adverse outcome (hazard ratio, 5.89; 95% confidence interval, 1.25–27.74; P=0.025), including 
after adjustment for baseline left ventricular end-diastolic volume. In the serial imaging time-course study, myocardial 
hemorrhage occurred in 7 (23%), 13 (43%), 11 (33%), and 4 (13%) patients 4 to 12 hours, 2 days, 10 days, and 7 months 
post reperfusion. The amount of hemorrhage (median [interquartile range], 7.0 [4.9–7.5]; % left ventricular mass) peaked 
on day 2 (P<0.001), whereas microvascular obstruction decreased with time post reperfusion.
Conclusions—Myocardial hemorrhage and microvascular obstruction follow distinct time courses post ST-segment–elevation 
MI. Myocardial hemorrhage was more closely associated with adverse outcomes than microvascular obstruction.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT02072850.   
(Circ Cardiovasc Imaging. 2016;9:e004148. DOI: 10.1161/CIRCIMAGING.115.004148.)
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hemorrhage reflects the aggregation and extravasation of eryth-
rocytes3,6,7 and is a manifestation of severe microvascular injury. 
Knowledge of the temporal evolution of these pathologies post 
STEMI would be relevant to inform the use of novel therapies 
intended to limit the progression of reperfusion injury and also 
to inform the timing of cardiac magnetic resonance (CMR) for 
surrogate end point assessment in clinical trials.
T2*-weighted CMR is the reference diagnostic method for 
myocardial hemorrhage in vivo8,9; however, technical issues 
have constrained T2* imaging in clinical practice. To date, the 
larger cohort studies of myocardial hemorrhage in patients with 
STEMI have not used T2* imaging,7,10–13 implying the lack of 
specificity. T2*-mapping has been used in smaller STEMI 
cohorts.14–16 These limitations are clinically relevant because of 
the uncertainties around the detection and clinical significance of 
myocardial hemorrhage and its relationships with microvascular 
obstruction. Myocardial hemorrhage is associated with adverse 
remodeling,10,12–14,16 persistent left ventricular (LV) systolic dys-
function,13,17 late arrhythmic risk,15 and adverse clinical out-
come18; however, myocardial hemorrhage may13 or may not10–12 
have prognostic significance beyond microvascular obstruction.
In this study, we aimed to (1) specifically detect myo-
cardial hemorrhage using T2* mapping in a large relatively 
unselected STEMI population and re-evaluate its pathophysi-
ology and prognostic significance, (2) study the temporal evo-
lution of myocardial hemorrhage with serial CMR early after 
reperfusion, and (3) assess the temporal relationships between 
myocardial hemorrhage versus microvascular obstruction.
We used quantitative T2* mapping that potentially offers 
increased accuracy for the detection of myocardial hemor-
rhage than T2-weighted methods8 because T2*-relaxation 
times are measured directly19–21 and is less sensitive to the 
effects of edema,22 which may mask hemorrhage.
Methods
Study Population and STEMI Management
We performed a prospective CMR cohort study of myocardial hem-
orrhage in acute reperfused STEMI survivors treated by emergency 
percutaneous coronary intervention (PCI), in a single-regional car-
diac center between July 14, 2011, and November 22, 2012. Three 
hundred twenty-four patients with STEMI provided written informed 
consent. This study was approved by the National Research Ethics 
Service (reference, 10-S0703-28).
Acute STEMI management followed contemporary guidelines23 
(Methods section in the Data Supplement). The study was publically 
registered (ClinicalTrials.gov identifier: NCT02072850).
CMR Acquisition
CMR was performed on a Siemens MAGNETOM Avanto (Erlangen, 
Germany) 1.5-Tesla scanner with a 12-element phased array cardiac 
surface coil 2 days and 6 months post MI.24 CMR was planned for 2 
days and 6 months in all participants.
The imaging protocol25,26 (Methods section in the Data 
Supplement) included cine CMR with steady-state free precession, 
T2* mapping, T2 mapping,19 and delayed-enhancement phase-sensi-
tive inversion-recovery pulse sequences.27 To respect the word count, 
the CMR methods are provided in the Data Supplement.
Serial Imaging Substudy
Thirty patients with STEMI underwent serial CMR to characterize 
the evolution of myocardial hemorrhage by T2 and T2* quantification 
and evaluate the temporal relationship with microvascular obstruc-
tion. Each patient was imaged at 4 time points, with the identical 
imaging protocol as above: 4 to 12 hours, 2 days, 10 days, and 6 to 7 
months post reperfusion.
Healthy Volunteers
CMR was also performed in 50 healthy volunteers of similar age and 
sex to obtain local reference values for myocardial T2 and T2* (Data 
Supplement). Patients and healthy volunteers underwent the same im-
aging protocol except that healthy volunteers aged <45 years did not 
receive gadolinium. The coefficients of variation for native T2 and 
T2* were also measured (Results section in the Data Supplement).
CMR Analyses
The CMR analyses are described in the Methods section in the Data 
Supplement.
T2 and T2*—Standardized Measurements in Myocardial 
Regions of Interest
LV contours were delineated with computer-assisted planimetry on 
the raw T2* image and the last corresponding T2 raw image, with 
echo time of 55 ms28 (Methods section in the Data Supplement).
Myocardial Hemorrhage
On the T2* maps, a region of reduced signal intensity within the in-
farcted area, with a T2* value of <20 ms14,16,20 was considered to con-
firm the presence of myocardial hemorrhage.
Infarct Definition and Size
The myocardial mass of late gadolinium (g) was quantified us-
ing computer-assisted planimetry24 (Methods section in the Data 
Supplement).
Area At Risk
Area at risk was defined as LV myocardium with pixel values (T2) >2 
SDs from remote myocardium.29–32
Myocardial Salvage
Myocardial salvage was calculated by subtraction of percent infarct 
size from percent area at risk.29–32 The myocardial salvage index was 
calculated by dividing the myocardial salvage area by the initial area 
at risk.
Adverse Remodeling
Adverse remodeling was defined as an increase in LV end-diastolic 
volume ≥20% at 6 months from baseline.33
Electrocardiogram
A 12-lead ECG was obtained before coronary reperfusion and 60 
minutes post procedure (Methods section in the Data Supplement). 
ECG evidence of reperfusion injury was taken as persistence of ST-
segment–elevation resolution post procedure.
Prespecified Health Outcomes
We prespecified adverse health outcomes that are pathophysiologi-
cally linked with STEMI. The primary composite outcome was car-
diovascular death or first heart failure hospitalization post discharge. 
Events that occurred during the index hospitalization were not count-
ed. The serious adverse events were independently assessed by an ac-
credited cardiologist who was not a member of the research team. The 
serious adverse events were defined according to standard criteria25,26 
and categorized as having occurred either during the index admission 
or post discharge. All study participants were followed up by patient 
contacts through telephone calls, clinic visits, and review of the elec-
tronic medical records for a minimum of 18 months after discharge.
Statistical Analyses
The sample size calculation and statistical methods are described in 
the Methods section in the Data Supplement. Categorical variables 
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are expressed as number and percentage of patients. Most continu-
ous variables followed a normal distribution and are therefore pre-
sented as means together with SD. Those variables that did not 
follow a normal distribution are presented as medians with interquar-
tile range. Differences between groups were assessed using 1-way 
ANOVA, Kruskal–Wallis test, or Fisher exact test where appropri-
ate. Agreement was assessed with Bland–Altman plots. For repeated 
measures, linear mixed effects modeling, with subject ID as a ran-
dom factor, was used. Binary logistic regression models were used 
to identify predictors of adverse remodeling at 6-month follow-up. 
Linear regressions were used to assess relationships in models with 
continuous responses. Where backward stepwise variable selection 
was used for either logistic or linear models, the Akaike information 
criterion was used a measure of the relative quality of the models, 
and the model with the minimum Akaike information criterion value 
was reported.
Cox proportional hazards methods were used to identify poten-
tial clinical predictors of cardiovascular death/heart failure events, 
including patient characteristics, CMR findings, and myocardial 
hemorrhage. The assumption of proportional hazards was verified 
by fitting an interaction between time and predictor. All statisti-
cal analyses were carried out using R version 2.15.1 or SAS ver-
sion 9.3, or later versions of these programs. A P value of >0.05 
indicates the absence of evidence for a statistically significant 
association.
Results
Of 324 patients with STEMI referred for emergency PCI, 300 
underwent serial CMR 2.1±1.8 days and 6 months after hos-
pital admission (Figure 1). Two hundred eighty-six patients 
with STEMI had T2* maps acquired. Two hundred forty-five 
(86%) patients had evaluable myocardial T2* data (Figure 1), 
and all of these patients had evaluable T2 maps. CMR follow-
up at 6 months was achieved in 228 (93%) of the patients with 
T2* mapping performed, and all (n=245) patients had health 
outcomes assessed at minimum of 18 months after enrollment.
Patient Characteristics
The clinical characteristics of the patients (n=245), categorized 
according to the presence or the absence of myocardial hemor-
rhage and microvascular obstruction 2 days post reperfusion, are 
shown in Table 1. One hundred one (41%) patients had myo-
cardial hemorrhage as specifically revealed by T2* maps. Male 
sex, anterior infarction, thrombolysis in MI flow ≤1 before PCI, 
Killip heart failure class >2 at presentation, and inflammation 
were more common in patients with myocardial hemorrhage. 
Patients with myocardial hemorrhage had less resolution of ST-
segment–elevation post PCI. At discharge, angiotensin-convert-
ing enzyme inhibitor and β-blocker therapies were prescribed in 
237 (97%) and 233 (95%) of patients, respectively.
Myocardial Hemorrhage and Associations With 
Clinical Characteristics and Inflammation
In stepwise logistic regression using Akaike information crite-
rion, myocardial hemorrhage was associated with sex, smok-
ing, history of previous PCI, thrombolysis in MI coronary flow 
grade at initial angiography, ECG evidence of reperfusion 
injury, Killip class, and markers of inflammation, including 
peak monocyte count and peak neutrophil count (all P<0.03; 
Table I in the Data Supplement).
Myocardial Hemorrhage Is Associated With 
Myocardial Infarct Characteristics
The CMR findings at 2 days post MI and 6 months later are shown 
in Table 2. Clinical cases are shown in Figure 2. Compared with 
patients without myocardial hemorrhage, patients with myo-
cardial hemorrhage had a larger LV mass, larger LV volumes, 
and lower LV ejection fractions early post MI and at 6 months. 
The initial area at risk, infarct size, and microvascular obstruc-
tion were also larger, and there was less myocardial salvage in 
patients with myocardial hemorrhage, (P<0.001; Table 2).
Comparison of Myocardial Hemorrhage (T2* Core), T2 
Hypointense Core, and Microvascular Obstruction
A hypointense infarct core was detected with T2 mapping in 
161 (66%) patients with STEMI. Microvascular obstruction 
with early and late gadolinium enhancement CMR was revealed 
in 151 (62%) and 133 (51%) patients, respectively. All patients 
with myocardial hemorrhage, as defined by T2* imaging, had 
late microvascular obstruction and a hypointense core on T2 
imaging. By contrast, 32 (13%) patients had late microvascular 
obstruction in the absence of myocardial hemorrhage, and all of 
these patients had a hypointense core on T2 imaging. Twenty-
eight (11%) patients had a T2 hypointense core without evidence 
of late microvascular obstruction or myocardial hemorrhage.
Figure 1. Study flow diagram. CMR indicates cardiac magnetic 
resonance; MRI, magnetic resonance imaging, and STEMI, ST-
segment–elevation myocardial infarction.
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Table 1. Clinical and Angiographic Characteristics of 245 Patients With Acute ST-Segment–Elevation Myocardial 
Infarction Who Had Cardiac Magnetic Resonance at Baseline, Including Evaluable T2* Maps
Characteristics*
All Patients, 
n=245
No Hemorrhage or 
MVO, n=112
MVO Only,  
n=32
Hemorrhage and  
MVO, n=101 P Value
Clinical
  Age, y 58 (11) 59 (11) 57 (11) 59 (12) 0.745
  Male sex, n (%) 187 (76) 82 (73) 21 (66) 84 (83) 0.047
  BMI, kg/m2 28 (5) 28 (5) 27 (3) 28 (5) 0.848
History
  Hypertension, n (%) 77 (31) 32 (29) 8 (25) 37 (37) 0.163
  Current smoking, n (%) 153 (62) 64 (57) 19 (59) 70 (69) 0.081
  Hypercholesterolemia, n (%) 68 (28) 32 (29) 5 (16) 31 (31) 0.469
  Diabetes mellitus,‡ n (%) 28 (11) 10 (9) 3 (9) 15 (15) 0.220
  Previous angina, n (%) 31 (13) 14 (13) 2 (6) 15 (15) 0.437
  Previous myocardial infarction, n (%) 17 (7) 9 (7) 1 (3) 8 (8) 0.619
  Previous PCI, n (%) 13 (5) 2 (2) 1 (3) 10 (10) 0.009
Presenting characteristics
  Heart rate, bpm 78 (16) 77 (16) 76 (15) 80 (17) 0.202
  Systolic blood pressure, mm Hg 136 (25) 137 (26) 132 (25) 136 (23) 0.887
  Diastolic blood pressure, mm Hg 80 (14) 79 (14) 76 (13) 82 (14) 0.074
  Time from symptom onset to reperfusion, min 176 (123–324) 166 (122–254) 208 (131–341) 207 (125–364) 0.161
  Ventricular fibrillation,† n (%) 15 (6) 5 (5) 3 (9) 7 (7) 0.788
  Heart failure, Killip class at presentation, n (%)
   I 171 (70) 87 (78) 25 (78) 59 (58) <0.001
   II 57 (23) 24 (21) 7 (22) 26 (26)
   III/IV 17 (7) 1 (1) 0 16 (16)
  ECG
  ST-segment–elevation resolution post PCI, n (%)
  None, ≤30% 38 (16) 13 (12) 3 (9) 31 (31) 0.001
   Partial, 30% to <70% 99 (41) 38 (34) 13 (41) 48 (47)
   Complete, ≥70% 107 (44) 60 (54) 16 (50) 22 (22)
Coronary angiography
  Reperfusion strategy, n (%)
   Primary PCI 229 (94) 106 (95) 31 (97) 92 (91) 0.173
   Rescue PCI (failed thrombolysis) 10 (4) 2 (2) 1 (3) 7 (7)
   Successful thrombolysis 6 (2) 4 (3) 0 2 (2)
  No. of diseased arteries,‡ n (%)
   1 132 (54) 55 (49) 19 (59) 58 (57) 0.714
   2 70 (29) 36 (32) 9 (28) 25 (25)
   3 37 (15) 18 (16) 3 (9) 16 (16)
  Culprit artery, n (%)
   LM 6 (2) 3 (3) 1 (3) 2 (2) 0.003
   LAD 96 (39) 39 (35) 11 (34) 46 (46)
   LCX 48 (20) 17 (15) 5 (16) 26 (26)
   RCA 101 (41) 56 (50) 16 (50) 29 (29)
  TIMI coronary flow grade pre PCI, n (%)
   0/1 180 (74) 67 (60) 25 (78) 88 (87) <0.001
   2/3 65 (27) 45 (40) 7 (22) 13 (13)
  TIMI coronary flow grade post PCI, n (%)
   0/1 3 (1) 1 (1) 0 2 (2) 0.570
   2/3 242 (99) 111 (99) 32 (100) 99 (98)
(Continued )
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The results of intraobserver and interobserver agreement 
of T2 and T2* core measurements are shown in Results sec-
tion in the Data Supplement.
Temporal Evolution of Myocardial Hemorrhage and 
Microvascular Obstruction From Acute Reperfusion 
Through to 6 Months
Thirty patients with STEMI underwent serial imaging on 4 suc-
cessive occasions, and their clinical characteristics (Table II in the 
Data Supplement) and CMR findings (Tables III and IV in the Data 
Supplement) were similar to those of the whole cohort. The imag-
ing time points post reperfusion were (mean±SD) 8.6±3.1 hours, 
2.9±1.5 days, 9.6±2.3 days, and 213±27 days (100% compliance).
Intramyocardial hemorrhage occurred in 7 (23%), 13 
(43%), 11 (33%), and 4 (13%) patients versus microvascular 
obstruction in 18 (60%), 17 (57%), 10 (33%), and 0 patients 
at 4 to 12 hours, 2 days, 10 days, and 7 months, respectively. 
The amount of microvascular obstruction (% LV mass) in 
patients with hemorrhagic infarction was at its greatest at 4 to 
12 hours post reperfusion and remained similar at day 2 CMR 
and then reduced by day 10 (P<0.001; Figure 3; Table V in 
the Data Supplement). By contrast, the amount of myocardial 
hemorrhage progressively increased from 4 to 12 hours with 
a peak at day 2 and decreased by day 10 (P<0.001; Figure 3). 
The amount of T2-hypointense core (% LV mass) followed a 
similar time course to hemorrhage (P<0.001; Figure 3). At 7 
months, 4 (13%) patients had evidence of persisting hemor-
rhage, but none of the patients had microvascular obstruction.
Persistence of Microvascular Obstruction in Relation to the 
Presence of Myocardial Hemorrhage
Microvascular obstruction revealed by late gadolinium enhance-
ment resolved by day 10 in 8 (44%) patients; 2 (25%) of whom 
had evidence of myocardial hemorrhage. Microvascular obstruc-
tion persisted at day 10 in 10 (56%) patients, and all (100%) of 
these patients had evidence of myocardial hemorrhage.
Myocardial Hemorrhage and Adverse Remodeling 
at 6 Months
At 6 months, LV end-diastolic volume increased on average 
(SD) by 6 (27) mL in 224 patients with evaluable data. The 
average increase in LV end-diastolic volume at 6 months was 
greater in patients with myocardial hemorrhage compared 
with those without (15 [30] versus 1 [22]; P<0.001). Adverse 
remodeling, defined as an increase in LV end-diastolic vol-
ume by ≥20%, occurred in 28 (13%) patients. The presence of 
myocardial hemorrhage (binary) was a multivariable associ-
ate of adverse remodeling, independent of baseline LV end-
diastolic volume (odds ratio [95% confidence interval], 2.64 
[1.07–6.49]; P=0.035; Table VI in the Data Supplement). In 
multivariable regression, T2* core (continuous, ms) was not 
significantly associated with adverse remodeling.
Myocardial Hemorrhage, Microvascular Obstruction, T2-
Hypointense Core, and LV Outcomes at 6 Months
The relationships for the presence of myocardial hemorrhage, 
T2 map core, and microvascular obstruction for LV outcomes, 
including LV end-diastolic volumes and LV ejection fraction, 
are shown in Table 3. Myocardial hemorrhage is consistently 
associated with worse LV outcomes 6 months post MI.
Myocardial Hemorrhage and N-Terminal Pro–Brain 
Natriuretic Peptide, a Biochemical Marker of LV 
Remodeling, at 6 Months
Myocardial hemorrhage was associated with N-terminal pro–
brain natriuretic peptide at 6 months (regression coefficient, 
174.57 [95% confidence interval, 37.85–311.29]; P=0.013), 
after adjustment for baseline LV ejection fraction, baseline 
LV end-diastolic volume, and baseline N-terminal pro–brain 
natriuretic peptide (Results section in the Data Supplement).
Myocardial Hemorrhage, Microvascular 
Obstruction, and Longer-Term Health Outcomes
Two hundred forty-five (100%) patients had longer term 
follow-up completed. The median duration of follow-up was 
830 days. Ten of 245 (4%) patients had a cardiovascular cause 
of death or experienced a heart failure event post discharge. 
Myocardial hemorrhage was associated with cardiovascular 
death or first hospitalization for heart failure post discharge, 
(hazard ratio, 5.89; 95% confidence interval, 1.25–27.74; 
P=0.025), including after adjustment for baseline LV end-
diastolic volume. Microvascular obstruction (P=0.22) and the 
Initial blood results on admission
  C-reactive protein, mg/L 3 (2–7) 3 (2–7) 4 (2–8) 3 (2–7) 0.116
  Leukocyte cell count, ×109 L 12.5 (3.5) 11.6 (3.3) 11.8 (2.5) 13.7 (3.8) <0.001
  Neutrophil count, ×109 L 9.7 (3.3) 8.8 (3.0) 9.0 (2.4) 11.0 (3.5) <0.001
  Monocytes, ×109 L 0.9 (0.4) 0.8 (0.3) 0.8 (0.3) 1.0 (0.5) <0.001
  NT-proBNP, pg/mL 767 (369–1633) 566 (260–1412) 799 (432–1946) 1044 (646–1642) 0.295
Patients are categorized according to the absence or the presence of myocardial hemorrhage and MVO, revealed by T2* maps and late gadolinium 
enhancement imaging, respectively. BMI indicates body mass index; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; LM, 
left main coronary artery; MVO, microvascular obstruction; NT-proBNP, N-terminal pro–brain natriuretic peptide; PCI, percutaneous coronary intervention; 
RCA, right coronary artery; and TIMI, thrombolysis in myocardial infarction.
*Data are reported as mean (SD), median (IQR), or n (%) as appropriate.
†Successfully electrically cardioverted ventricular fibrillation at presentation or during emergency PCI procedure. 
‡Diabetes mellitus was defined as a history of diet-controlled or treated diabetes.
Table 1. Continued
Characteristics*
All Patients, 
n=245
No Hemorrhage or 
MVO, n=112
MVO Only,  
n=32
Hemorrhage and  
MVO, n=101 P Value
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hypointensive core on T2 mapping (P=0.31) were not associ-
ated with cardiovascular death or heart failure post discharge.
Discussion
We have undertaken the largest clinical study to date of myo-
cardial hemorrhage using diagnostic T2* CMR mapping in 
a comparatively large unselected population of patients with 
acute STEMI. We have also reported for the first time a serial 
imaging time-course study of myocardial hemorrhage and 
microvascular obstruction.
Our main findings are as follows: (1) the incidence of 
myocardial hemorrhage was 41%, and hemorrhage occurred 
less frequently and was less extensive in size than microvas-
cular obstruction revealed by contrast-enhanced CMR or the 
Table 2. Baseline and 6-Month CMR Findings in 245 Patients With ST-Segment–Elevation Myocardial Infarction 
According to the Presence or the Absence of Myocardial Hemorrhage and Microvascular Obstruction
Characteristics* All Patients, n=245
No Hemorrhage 
or MVO, n=112
MVO only,  
n=32
Hemorrhage and  
MVO, n=101 P Value
CMR findings 2 d post MI
  LV ejection fraction, % 55 (10) 58 (9) 56 (8) 51 (10) <0.001
  LV end-diastolic volume, mL
   Men 161 (32) 152 (33) 157 (25) 171 (31) <0.001
   Women 124 (23) 122 (24) 126 (20) 127 (26) 0.534
  LV end-systolic volume, mL
   Men 76 (26) 67 (24) 71 (16) 86 (27) <0.001
   Women 55 (15) 52 (15) 55 (11) 62 (16) 0.037
  LV mass, g
   Men 146 (34) 139 (30) 147 (28) 154 (38) 0.006
   Women 99 (24) 94 (23) 94 (14) 111 (26) 0.010
Edema and infarct characteristics
  Area at risk, % LV mass 33 (12) 27 (10) 34 (9) 39 (11) <0.001
  Infarct size, % LV mass 19 (14) 10 (9) 20 (9) 29 (12) <0.001
  Myocardial salvage, % of LV mass 19 (9) 20 (10) 20 (9) 18 (8) 0.064
  Myocardial salvage index, % 61 (24) 75 (23) 59 (20) 46 (17) <0.001
  Late microvascular obstruction 
present, n (%)
133 (54) 0 32 (100) 101 (100) <0.001
  Late microvascular obstruction, % 
LV mass
0.5 (0.0–4.2) … 1.2 (0.7–2.4) 5.3 (2.1–9.5) <0.001
  T2 hypointense core present, n (%) 161 (66) 28 (25) 32 (100) 101 (100) <0.001
CMR findings 6 mo post MI (n=228)
  LV ejection fraction, % 61 (9) 66 (7) 63(6) 56 (10) <0.001
  Change in LV ejection fraction at 6 
mo from baseline, %
7 (8) 8 (8) 7 (7) 5 (7) 0.005
  LV end-diastolic volume, mL
   Men 169 (42) 152 (30) 160 (27) 188 (48) <0.001
   Women 128 (23) 125 (24) 132 (24) 133 (20) 0.066
  Change in LV end-diastolic volume at 6 mo from baseline, mL
   Men 7 (29) −1 (25) 2 (18) 17 (32) <0.001
   Women 3 (19) 0 (18) 8 (18) 5 (21) 0.621
  LV end-systolic volume, mL
   Men 69 (35) 54 (21) 60 (17) 86 (42) <0.001
   Women 48 (17) 41 (14) 49 (15) 62 (13) <0.001
  Change in LV end-systolic volume at 6 mo from baseline, mL
   Men −7 (24) −14 (21) −11 (14) 0 (28) <0.001
   Women −7 (14) −11 (14) −4 (8) 0 (14) 0.023
  LV mass, g
   Men 128 (27) 122 (27) 128 (22) 133 (28) 0.007
   Women 91 (18) 90 (19) 90 (17) 95 (17) 0.270
CMR indicates cardiac magnetic resonance; MVO, microvascular obstruction; LV, left ventricular; and MI, myocardial infarction.
*Data are reported as mean (SD), median (IQR), or n (%) as appropriate.
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hypointense core revealed by T2 mapping; (2) myocardial 
hemorrhage was associated with clinical characteristics indica-
tive of more severe MI and systemic inflammation; (3) myo-
cardial hemorrhage was independently associated with adverse 
LV remodeling at 6 months and cardiovascular death and first 
hospitalization for heart failure; (4) considering the time course, 
myocardial hemorrhage occurred in ≈1 quarter of the patients 
within 12 hours of reperfusion, and the incidence approximately 
Figure 2. Three patients with acute ST-segment–elevation myocardial infarction treated by primary percutaneous coronary intervention 
(PCI) using the same antithrombotic strategies. Each patient had normal thrombolysis in myocardial infarction grade 3 flow at the end 
of PCI. Cardiac magnetic resonance imaging was performed 2 days post reperfusion. A, Patient with no evidence of myocardial hemor-
rhage or microvascular obstruction. B, Patient with T2-hypointense core and microvascular obstruction, in the absence of hemorrhage. 
C, Patient with myocardial hemorrhage (Results section in the Data Supplement).
Figure 3. Temporal evolution of the extent of microvascular obstruction (MVO; top, blue line), the hypointense core revealed by T2 map-
ping (middle, green line), and myocardial hemorrhage (bottom, red line) revealed by T2* mapping according to time from coronary reper-
fusion in 28 ST-segment–elevation myocardial infarction survivors. Data are presented as median (interquartile range) percentage of left 
ventricular (LV) mass. The amount of MVO and T2-hypointense core were calculated using full LV coverage, whereas the amount of myo-
cardial hemorrhage was derived from 3 scans from the basal, mid, and apical slice acquisitions. P values were obtained from linear mixed 
effects model with subject as a random factor. MRI indicates magnetic resonance imaging.
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doubled by day 2, indicating secondary progression after the 
acute bleed; (5) the early progressive evolution of myocardial 
hemorrhage was distinct from microvascular obstruction that was 
maximal 4 to 12 hours post MI and then decreased subsequently; 
(6) a hypointense infarct core on T2 mapping always occurred in 
the presence of microvascular obstruction and commonly in the 
absence of myocardial hemorrhage within 12 hours and 2 days 
post MI, indicating that the presence of T2 core is more closely 
associated with microvascular obstruction than myocardial hem-
orrhage; and (7) myocardial hemorrhage was more consistently 
associated with adverse surrogate outcomes (LV remodeling 
and N-terminal pro–brain natriuretic peptide) and spontaneous 
adverse health outcomes (cardiovascular death or heart failure 
post discharge) than microvascular obstruction.
To date, our understanding of the natural history of reperfu-
sion hemorrhage has been limited by constraints with diagnos-
tic methods. Most studies have used dark blood T2-weighted 
imaging to detect hemorrhage10–13,18; however, this qualitative 
technique is hampered by imaging artifact,34 false-positive 
effects of microvascular obstruction,35,36 and lack of specificity 
for the detection of myocardial hemorrhage. Methodological 
issues, such as the use of dark-blood T2-weighted imaging and 
the inclusion of incident adverse cardiac events during the index 
hospitalization, may have confounded the results of previous 
prognostic studies such that the clinical significance of myo-
cardial hemorrhage, as a deleterious complication or simple 
bystander of infarct severity, was uncertain. Taken together, our 
results indicate that the time course and prognostic significance 
of myocardial hemorrhage are distinctly significant.
T2-weighted imaging is strongly influenced by edema, and 
the hyperintense signal from edema may mask a hypointense 
signal because of localized infarct core hemorrhage.22 On the 
other hand, T2* imaging is relatively insensitive to the effects 
of edema.8 Quantitative T2 mapping addresses the limitations 
associated with T2-weighted techniques,22,34–36 offers increased 
accuracy in the detection of myocardial edema, and may provide 
a more objective assessment of the infarct core because T2 relax-
ation times are more directly estimated.19–21 We observed that the 
hypointense core on T2 mapping is more closely associated with 
late microvascular obstruction than myocardial hemorrhage, as 
specifically revealed by T2* mapping.
To date, the temporal evolution of myocardial hemorrhage 
and its relationship with microvascular obstruction early after 
reperfusion have been incompletely understood. Experimental 
studies have noted that hemorrhage occurs as a consequence of 
reperfusion,37 whereas other studies have observed that hem-
orrhage may be a secondary phenomenon because of progres-
sive capillary breakdown.6,7,9 A recent experimental study by 
Robbers et al7 indicated that microvascular obstruction might be 
a modifiable precursor of hemorrhage, which represented irre-
versible microvascular destruction. In our study, we observed 
that microvascular obstruction occurred maximally 4 to 12 hours 
post reperfusion, whereas, by contrast, myocardial hemorrhage 
increased progressively from a zero baseline, through 4 to <12 
hours to a peak 2 days after reperfusion followed by a reduc-
tion at 10 days. Also, in accordance with other recent studies 
using T2* imaging,8,9,16,17,21 we observed that hemorrhage only 
occurred within regions of microvascular obstruction. Therefore, 
in agreement with the preclinical findings of Robbers et al,7 our 
time-course analysis supports the conclusion that hemorrhage is 
a downstream consequence of microvascular obstruction.
Previous studies using dark-blood T2-weighted imaging 
to define hemorrhage showed that microvascular obstruction 
occurred commonly in the absence of a T2 hypointense core.18 
In contrast, we observed that all patients with microvascular 
obstruction had a hypointense core on T2 mapping. Our results 
are supported by a postmortem analysis,36 which showed that a 
T2 hypointense core always represented microvascular obstruc-
tion, with or without hemorrhage and by a recent clinical 
study by Symons et al13 in 186 patients with recent STEMI. In 
their study, all patients with a hypointense core on dark-blood 
T2-weighted CMR had concomitant microvascular obstruction, 
and the combination of these pathologies was more strongly 
associated with adverse LV remodeling than microvascular 
obstruction alone. Our analysis extends these findings by identi-
fying associations between myocardial hemorrhage revealed by 
T2* CMR and baseline clinical characteristics (ie, the severity 
of MI and inflammation) and multivariable associations with LV 
remodeling and with adverse health outcomes.
We also observed that the presence and extent of a hypoin-
tense core disclosed by T2 mapping were more closely related 
to early microvascular obstruction than late microvascular 
obstruction or hemorrhage. We postulate that the occurrence 
of a T2 hypointense core in the absence of hemorrhage most 
likely represents a reduction in the effective tissue water con-
tent within the infarct core because of obstruction of capillary 
blood flow (eg, cellular debris and extrinsic edema) and micro-
vascular spasm, thereby reducing the amount of tissue water 
content and shortening T2 relaxation (ms) within the infarct 
core.19 Furthermore, we observed that the size of the hypoin-
tense core on T2 imaging was greater than the extent of micro-
vascular obstruction and hemorrhage (Figure 3) consistent with 
observations in experimental MI.7 There are conflicting data on 
the temporal change in size of microvascular obstruction in the 
early reperfusion period. Canine studies38,39 have shown that the 
amount of microvascular obstruction increases in the first 48 
hours after reperfusion and then remains stable between 2 and 9 
days. However, there have not been any confirmatory studies in 
humans to demonstrate expansion of microvascular obstruction 
at any time point post reperfusion. Our findings indicate that the 
extent of microvascular obstruction remains stable between 4 
to 12 hours and day 2 and then decreases to day 10, which is in 
agreement with other clinical data.40,41
Table 3. Coefficients, 95% CIs, and P Values From Linear 
Regression for the Associations of the Presence of Myocardial 
Hemorrhage (T2* Core) and T2-Map Infarct Core and MVO, 
With Changes in Left Ventricular Volume and Ejection Fraction 
at 7 Months, Adjusted for Baseline
Change in Left Ventricular  
End-Diastolic Volume, mL
Change in Left Ventricular 
Ejection Fraction, mL
Regression Coefficient  
(95% CI); P Value
Regression Coefficient 
(95% CI); P Value
T2* core (binary) 16.70 (9.54 to 23.86); <0.001 −5.93 (−7.79 to −4.06); 
<0.001
T2 core (binary) 12.11 (4.70 to 19.51); 0.001 −5.12 (−7.05 to −3.19); 
<0.001
MVO (binary) 14.57 (7.50 to 21.64); <0.001 −4.90 (−6.78 to −3.01); 
<0.001
CI indicates confidence interval; and MVO, microvascular obstruction.
D
ow
nloaded from
 http://ahajournals.org by on May 1, 2019
9  Carrick et al  Myocardial Hemorrhage in STEMI Survivors 
Our results have important clinical implications. Because 
hemorrhage increases progressively early and post MI, it may be 
modifiable with targeted preventive therapy to restore microvas-
cular perfusion and preserve capillary integrity. This possibility is 
undergoing prospective assessment in T-TIME (NCT02257294), 
which is a randomized placebo-controlled clinical trial of reduced 
doses of alteplase for intracoronary thrombolysis immediately 
after reperfusion during primary PCI. Alternatively, CMR with 
T2* mapping could be used to identify myocardial hemorrhage 
in STEMI survivors who might benefit from more intensive ther-
apy or novel therapies designed to prevent adverse LV ventricular 
remodeling. Further studies are warranted.
Limitations
Our study lacks pathological correlation of the imaging results. 
As a result of time constraints reflecting the duration of the CMR 
scan, we only acquired 3 short-axis slices using T2* mapping, 
and therefore, minor degrees of hemorrhage could have been 
missed. The amount of hemorrhage was calculated from 3 slice 
positions (basal, mid, and apical) rather than a full LV stack to 
constrain the total duration of the CMR scan. The T2* acquisi-
tion was associated with imaging artifacts that limited the quan-
tification of hemorrhage in some patients, and only 86% of the 
initial cohort had analyzable T2* data. Future improvements to 
T2* mapping could include the use of high-pass filtered process-
ing42 and the use of an automated truncation method.43
Conclusions
We found that myocardial hemorrhage occurs commonly 
and follows a progressive time course within the first 2 days 
post MI that is distinct from microvascular obstruction. The 
occurrence of myocardial hemorrhage is prognostically more 
significant than microvascular obstruction. Our findings are 
relevant for risk assessment in STEMI survivors and for the 
development and assessment of novel therapies to limit reper-
fusion injury and infarct size post STEMI.
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CLINICAL PERSPECTIVE
Myocardial perfusion remains compromised in ≤50% of patients with ST-segment–elevation myocardial infarction, despite rapid 
and successful mechanical revascularization of the culprit artery. Although pathological and clinical observations initially seemed 
to support the theory that no reflow was a consequence of microvascular obstruction, irreversible microvascular injury and sub-
sequent myocardial hemorrhage are now also thought to play important factors in this process. The clinical significance of myo-
cardial hemorrhage is uncertain, as is the temporal evolution and inter-relationships with microvascular obstruction. T2* cardiac 
magnetic resonance is considered the gold standard for in vivo myocardial hemorrhage visualization post myocardial infarction. 
This study shows that myocardial hemorrhage is associated with adverse remodeling and adverse health outcome in the longer 
term. In addition, the occurrence of myocardial hemorrhage is prognostically more significant than microvascular obstruction. The 
results of our serial imaging time-course substudy show that myocardial hemorrhage follows a progressive time course within the 
first 2 days post myocardial infarction and is distinct from microvascular obstruction, which decreases with time post reperfusion. 
Our findings are relevant for risk assessment in ST-segment–elevation myocardial infarction survivors. Furthermore, a detailed 
knowledge of the early dynamic changes of both hemorrhage and microvascular obstruction is critical to the development and 
assessment of novel therapies to limit reperfusion injury and infarct size post ST-segment–elevation myocardial infarction.
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